The goal of the present studies was to investigate the role of changes in hydrogen sulfide (H 2 S) homeostasis in the pathogenesis of hyperglycemic endothelial dysfunction. Exposure of bEnd3 microvascular endothelial cells to elevated extracellular glucose (in vitro "hyperglycemia") induced the mitochondrial formation of reactive oxygen species (ROS), which resulted in an increased consumption of endogenous and exogenous H 2 S. Replacement of H 2 S or overexpression of the H 2 S-producing enzyme cystathionine-γ-lyase (CSE) attenuated the hyperglycemia-induced enhancement of ROS formation, attenuated nuclear DNA injury, reduced the activation of the nuclear enzyme poly(ADP-ribose) polymerase, and improved cellular viability. In vitro hyperglycemia resulted in a switch from oxidative phosphorylation to glycolysis, an effect that was partially corrected by H 2 S supplementation. Exposure of isolated vascular rings to high glucose in vitro induced an impairment of endothelium-dependent relaxations, which was prevented by CSE overexpression or H 2 S supplementation. siRNA silencing of CSE exacerbated ROS production in hyperglycemic endothelial cells. Vascular rings from CSE −/− mice exhibited an accelerated impairment of endothelium-dependent relaxations in response to in vitro hyperglycemia, compared with wild-type controls. Streptozotocininduced diabetes in rats resulted in a decrease in the circulating level of H 2 S; replacement of H 2 S protected from the development of endothelial dysfunction ex vivo. In conclusion, endogenously produced H 2 S protects against the development of hyperglycemia-induced endothelial dysfunction. We hypothesize that, in hyperglycemic endothelial cells, mitochondrial ROS production and increased H 2 S catabolism form a positive feed-forward cycle. H 2 S replacement protects against these alterations, resulting in reduced ROS formation, improved endothelial metabolic state, and maintenance of normal endothelial function.
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The goal of the present studies was to investigate the role of changes in hydrogen sulfide (H 2 S) homeostasis in the pathogenesis of hyperglycemic endothelial dysfunction. Exposure of bEnd3 microvascular endothelial cells to elevated extracellular glucose (in vitro "hyperglycemia") induced the mitochondrial formation of reactive oxygen species (ROS), which resulted in an increased consumption of endogenous and exogenous H 2 S. Replacement of H 2 S or overexpression of the H 2 S-producing enzyme cystathionine-γ-lyase (CSE) attenuated the hyperglycemia-induced enhancement of ROS formation, attenuated nuclear DNA injury, reduced the activation of the nuclear enzyme poly(ADP-ribose) polymerase, and improved cellular viability. In vitro hyperglycemia resulted in a switch from oxidative phosphorylation to glycolysis, an effect that was partially corrected by H 2 S supplementation. Exposure of isolated vascular rings to high glucose in vitro induced an impairment of endothelium-dependent relaxations, which was prevented by CSE overexpression or H 2 S supplementation. siRNA silencing of CSE exacerbated ROS production in hyperglycemic endothelial cells. Vascular rings from CSE −/− mice exhibited an accelerated impairment of endothelium-dependent relaxations in response to in vitro hyperglycemia, compared with wild-type controls. Streptozotocininduced diabetes in rats resulted in a decrease in the circulating level of H 2 S; replacement of H 2 S protected from the development of endothelial dysfunction ex vivo. In conclusion, endogenously produced H 2 S protects against the development of hyperglycemia-induced endothelial dysfunction. We hypothesize that, in hyperglycemic endothelial cells, mitochondrial ROS production and increased H 2 S catabolism form a positive feed-forward cycle. H 2 S replacement protects against these alterations, resulting in reduced ROS formation, improved endothelial metabolic state, and maintenance of normal endothelial function.
H ydrogen sulfide (H 2 S) is an endogenously produced labile diffusible mediator with multiple roles in the cardiovascular system in health and disease (1) (2) (3) (4) . Cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase are key enzymes involved in its production of H 2 S (3-6). CSE is primarily responsible for most of the H 2 S production in the vasculature (2, 3). The roles of H 2 S in the cardiovascular system include vasodilatation (7, 8) and stimulation of angiogenesis (9, 10) .
Endothelial dysfunction (the inability of the vascular endothelial cells to produce vasorelaxant mediators such as nitric oxide) plays a key role in the pathogenesis of various diabetic complications (11, 12) . Overproduction of mitochondrial reactive oxygen species (ROS) is a principal contributor to the pathogenesis of hyperglycemic endothelial dysfunction (11) (12) (13) (14) . Because H 2 S production and degradation is a dynamic process in biological systems, and ROS can enhance the degradation of H 2 S (15-17), here we tested whether hyperglycemia results in a H 2 S-deficient state and examined whether H 2 S replacement affects the development of hyperglycemic endothelial dysfunction in vitro and in vivo.
Results
In Vitro Hyperglycemia Is Associated with Increased H 2 S Degradation Caused by Mitochondrial ROS Overproduction. Exposure of endothelial cells to elevated glucose for 7 d resulted in a significant suppression of the H 2 S concentration in the supernatant (Fig. 1A) . Incubation of the cells with the ROS scavenger Tempol increased the H 2 S concentration in the medium (Fig. 1A ), suggesting that the reduced H 2 S level in hyperglycemia may be attributable to increased consumption of H 2 S by ROS. Administration of H 2 S to culture medium (without cells) resulted in a decline of ambient H 2 S concentrations because of the reaction of H 2 S with oxygen and culture media constituents. The consumption of H 2 S was increased in the presence of normoglycemic cells and was further accelerated in the presence of hyperglycemic cells (Fig. 1B) . Addition of the mitochondrial uncoupling agent carbonyl cyanide 3-chlorophenylhydrazone (CCCP) to hyperglycemic cells resulted in a slower consumption rate of H 2 S (Fig. 1B) , consistent with the hypothesis that mitochondrially derived ROS production contributes to the increase in H 2 S consumption in hyperglycemic cells. The increased mitochondrial ROS production in hyperglycemic cells was demonstrated by the redox-sensitive dye MitoSOX red; ROS production was reduced by the uncoupling agents CCCP and thenoyltrifluoroacetone (TTFA) (Fig. 1C) , confirming previous studies (11) (12) (13) (14) showing that mitochondria represent a major source of ROS.
H 2 S Replacement Exerts Cytoprotective Effects in Hyperglycemic
Endothelial Cells in Vitro. Addition of H 2 S (100-300 μΜ) for the last 4 d of the 7 d of the hyperglycemic period provided a concentration-dependent protection against cellular ROS production ( Fig. 2 A and B) and attenuated mitochondrial membrane depolarization as measured by the fluoroprobe 5,5′,6,6′-tetrachloro-1,1′3,3′-tetraethylbenzamidazol-carboncyanine (JC-1) (Fig. 2C) . Exposure of the cells to intermittent high-/low-glucose conditions is known to exacerbate hyperglycemic endothelial dysfunction (18) (19) (20) . Accordingly, intermittent high/low glucose induced a more pronounced increase in ROS production compared with a steady elevation of glucose, and H 2 S continued to attenuate this response ( Fig. 2A) . H 2 S administration also reduced DNA injury (Fig. S1A ) and the activation of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (Fig. S1B) , which are known downstream consequences of mitochondrial ROS formation in hyperglycemic endothelial cells (11) (12) (13) (14) . Overexpression of CSE in endothelial cells elevated extracellular H 2 S levels in normoglycemic cells (by 32 ± 5%), but only to a smaller degree in hyperglycemic cells (by 10 ± 3%), consistently with the increased consumption of H 2 S during hyperglycemia, as demonstrated above. Overexpression of CSE attenuated the hyperglycemia-induced increase in ROS production (Fig. 3A) . Both pharmacological replacement of H 2 S and overexpression of CSE protected against the hyperglycemia-induced decline in cellular viability. For instance, hyperglycemia decreased cell viability by 18 ± 2% (P < 0.05), whereas in the endothelial cells overexpressing CSE, cell viability increased by 6 ± 3%, compared with normoglycemic controls (n = 4).
Mechanisms of the Cytoprotective Effect of H 2 S in Hyperglycemic
Endothelial Cells. Analysis of the cellular metabolic status of the cells showed that high glucose induces a shift away from the mitochondrial oxidative phosphorylation toward glycolysis: the basal respiratory capacity and the respiratory reserve capacity response to carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) were reduced in hyperglycemic cells, compared with the normoglycemic cells (Fig. 4) . Treatment of the cells with H 2 S resulted LG) or high (40 mM, HG) glucose was determined by the amperometric H 2 S sensor method at 7 d. H 2 S levels in high glucose were significantly suppressed (*P < 0.05 compared with low glucose), an effect that was attenuated by the antioxidant Tempol (100 μM) ( # P < 0.05; n = 5). (B) The rate of consumption of exogenous H 2 S was measured by the amperometric H 2 S sensor. Cells were incubated for 7 d in low and high glucose, respectively, at which point a single concentration of H 2 S (300 mM) was added to the medium. There was a significant (*P < 0.05) increase in the rate of decline in H 2 S concentrations in cells incubated with high glucose, an effect that was attenuated ( # P < 0.05) by treatment of the hyperglycemic cells with the uncoupling agent CCCP (0.5 μM) (n = 5). (C) MitoSOX red oxidation was increased in cells exposed to high glucose (*P < 0.05), and this effect was significantly inhibited by H 2 S (300 μM) ( # P < 0.05) or by the uncoupling agents TTFA (10 μM) and CCCP (0.5 μM) ( # P < 0.05; n = 5).
Fig. 2.
Replacement of H 2 S normalizes mitochondrial oxidant production and protects against mitochondrial depolarization in endothelial cells placed in high extracellular glucose. Mitochondrial ROS production was measured in low (5.5 mM, LG) or high (40 mM, HG) glucose conditions at 7 d by using the MitoSOX red method. A shows the responses to H 2 S (100-300 μM) in no glucose, high glucose, and alternating high/low extracellular glucose conditions (H/L). H 2 S afforded a concentration-dependent and significant suppression of MitoSOX oxidation ( # P < 0.05). The Western blot Inset in A shows that the expression of the H 2 S-generating enzyme CSE was not suppressed by high glucose. B shows representative flow cytometric and fluorescent microscopic images for the four respective groups (low and high glucose with and without 300 μM H 2 S). C shows the oxidation of JC-1, a dye used to detect mitochondrial membrane depolarization. In cells placed in high glucose, there was an increase in mitochondrial depolarization (*P < 0.05), which was attenuated by H 2 S (P < 0.05) (n = 5).
in an improvement of mitochondrial respiration, whereas the hyperglycemia-induced increase in the glycolytic activity of the cells was normalized (Fig. 4 ). There were no marked alterations in the cellular ATP levels in hyperglycemic cells, likely because of the compensatory effect of increased glycolysis (ATP levels decreased to 88 ± 1% in hyperglycemic endothelial cells vs. normoglycemic endothelial cells; n = 3, P < 0.05). H 2 S prevented the hyperglycemia-induced suppression of cellular ATP levels (104 ± 2% of control normoglycemic cells, n = 3). Thus, H 2 S treatment produced a partial reversal of the hyperglycemia-induced metabolic switch and normalized the energetic status of the cells. As opposed to the effects of H 2 S administration for 4 d (see above), a short period of H 2 S administration (the last 60 min of the hyperglycemic period) failed to affect the mitochondrial ROS overproduction (Fig. S2) . Thus, although high concentrations of H 2 S are known to inhibit mitochondrial cytochrome c oxidase, resulting in a suppression of mitochondrial oxidative phosphorylation (21-23), the present effects of H 2 S in decreasing mitochondrial ROS production in hyperglycemic endothelial cells are not mediated by an acute suppression of mitochondrial function.
The expression of CSE (a principal H 2 S-producing enzyme in vascular tissues) was not affected by exposure of the endothelial cells to elevated glucose for 7 d (Fig. 2A) . Furthermore, the effects of H 2 S in hyperglycemic endothelial cells did not depend on the activation of the ATP-sensitive potassium (K ATP ) channel because the K ATP channel blocker glibenclamide failed to reverse the protective effect of H 2 S (Fig. S3 ).
H 2 S Replacement Therapy Improves Endothelial Function in Hyper-
glycemic Endothelial Cells and in Diabetic Rats. Overexpression of CSE in rat aortic rings produced a significant protection against the development of endothelial dysfunction induced by elevated extracellular glucose (Fig. 5) . Pharmacological supplementation of H 2 S yielded a similar protective effect (Fig. S4) . Streptozotocindiabetic rats exhibited a decrease in their blood H 2 S concentrations (Fig. 6A ) without any change in the tissue expression of CSE or CBS (Fig. S5 ). H 2 S replacement therapy did not affect circulating glucose levels in the diabetic animals ( Fig. 6B) but protected against the development of diabetes-induced endothelial dysfunction ex vivo (Fig. 6C) .
Absence of CSE Exacerbates Hyperglycemic Endothelial Cell Dysfunction.
In endothelial cells where endogenous H 2 S production was suppressed by siRNA knockdown of CSE, high glucose induced a more pronounced degree of ROS production than in the corresponding control cells (Fig. 3B) . Moreover, in thoracic aortic rings from CSE −/− mice, incubation in extracellular glucose for 24 h caused a more pronounced impairment of endothelium-dependent relaxations than in corresponding rings from wild-type mice (Fig. 7) . These results point to the protective role of endogenously produced H 2 S against hyperglycemic endothelial dysfunction.
Discussion
The formation of ROS from endothelial cells is a key factor in the pathogenesis of diabetic complications (11, 12) . In addition, increased ROS formation and endothelial dysfunction has been linked to various forms of critical illness, to postoperative conditions, as well as to impaired glucose tolerance conditions and postprandial hyperglycemia (11, 12, (24) (25) (26) (27) (28) (29) (30) (31) . Mitochondrial electron transport is recognized as a key source of ROS in hyperglycemic endothelial cells (11, 12) . ROS, on their own and by combining with endothelial nitric oxide to form the reactive oxidant peroxynitrite, can induce DNA damage and activation of suicidal pathways governed by the nuclear enzyme PARP (32) .
The biosynthesis of H 2 S, as well as the biological degradation (consumption) of H 2 S, is a dynamic process (3, 5, 15) . The current results point to the existence of a crucial interplay between endothelial H 2 S formation and ROS production in maintaining mitochondrial function: elevated glucose perturbs this balance. Our data demonstrate that the consumption of H 2 S is accelerated in endothelial cells placed in elevated glucose, an effect that depends on mitochondrial ROS formation (because it can be attenuated by mitochondrial uncoupling). It is conceivable that this accelerated H 2 S consumption is responsible for the lower baseline levels of H 2 S detected in the medium of cells placed in elevated extracellular glucose and for the decreased H 2 S levels measured in the circulation of streptozotocindiabetic rats. On the other hand, down-regulation of CSE does not occur in hyperglycemia and diabetes under our experimental conditions and, therefore, is not responsible for the reduced H 2 S levels.
H 2 S, as a reducing agent and an antioxidant molecule, has been previously shown to protect various cell types from oxidative injury (33) (34) (35) (36) . Based on the current results, we hypothesize that H 2 S provides a reducing/antioxidant intracellular environment that contributes to the maintenance of normal mitochondrial function. This balance is perturbed when mitochondrial ROS production is stimulated by high concentrations of glucose. We hypothesize that the ROS from hyperglycemic mitochondria directly reacts with and consumes the intracellular H 2 S, which then creates additional mitochondrial dysfunction, possibly by oxidative modification to mitochondrial proteins. Such a positive feed-forward cycle may then culminate in a dysfunctional mitochondrial state where molecular oxygen is used to produce ROS (as opposed to ATP) and where mitochondrial efficacy is diminished. These events will lead to a loss of mitochondrial membrane potential and, finally, a spillage of ROS to the cytosolic and nuclear compartments. Fig. 3 . Overexpression of CSE attenuates mitochondrial oxidant production in endothelial cells placed in high extracellular glucose, whereas silencing of CSE exacerbates this response. Mitochondrial ROS production was measured in low (LG) or high (HG) glucose at 7 d by using the MitoSOX red method. In response to elevated extracellular glucose, an increase in MitoSOX red oxidation was observed (*P < 0.05), which was attenuated when cells were overexpressing CSE ( # P < 0.05; A) and enhanced when CSE was silenced with siRNA ( # P < 0.05; B) (n = 4). The Western blot Insets confirm efficient CSE overexpression and knockdown, respectively.
Previous studies have demonstrated that antioxidant depletion is a hallmark of hyperglycemia in endothelial cells (37) (38) (39) . It has also been demonstrated previously that endothelial ROS overproduction leads to oxidative and nitrosative protein modifications, DNA injury, and activation of secondary deleterious cellular cycles of injury, such as the one governed by the activation of PARP (11-14, 18-20, 32) . The beneficial effects of antioxidants on the endothelial function in hyperglycemia may be, at least in part, related to the preservation of the endothelial H 2 S homeostasis.
The current bioenergetic findings, in agreement with a recent analysis of bioenergetic alterations in rat retinal endothelial cells placed in high extracellular glucose (40) , demonstrate that bEnd3 endothelial cells placed in high extracellular glucose exhibit a reduced oxygen consumption rate (i.e., reduced mitochondrial oxidative phosphorylation), an effect that is partially counterbalanced by an up-regulation of glycolysis. Our results also demonstrate that H 2 S replacement therapy protects against this pathophysiological switch between oxidative phosphorylation and glycolysis. We conclude that restoration of oxidative phosphorylation, coupled with an improvement of cellular ATP levels, mitochondrial depolarization, and mitochondrial ROS production are the key intracellular events through which H 2 S replacement is able to restore normal cellular function in hyperglycemic endothelial cells and prevent the development of endothelial dysfunction.
The results of the current study demonstrate that replacement of the H 2 S, either by supplementation into the culture medium or by overexpression of the H 2 S-producing enzyme CSE, is able to protect from the deleterious consequences of hyperglycemia. On the other hand, siRNA silencing of CSE, or the deletion of the CSE gene, results in conditions where hyperglycemia induces an exacerbated endothelial response (more ROS production and more severe loss of endothelium-dependent relaxant function), consistent with the hypothesis that endogenous H 2 S plays a protective role against the deleterious consequences of hyperglycemia in endothelial cells.
Our in vivo/ex vivo observations, showing that supplementation of H 2 S to streptozotocin-diabetic rats improves the endothelium-dependent relaxant function of vascular rings, are consistent with our in vitro findings in endothelial cells. Also, previous studies have demonstrated that pharmacological interventions (e.g., ROS scavenging, peroxynitrite neutralization, PARP inhibition) that protect hyperglycemic endothelial cells are also able to improve endothelium-dependent relaxations in diabetic rodents (11, 12, (29) (30) (31) (32) , and, therefore, prevention of the activation of these downstream pathways is likely to contribute to the effects of H 2 S in the current experimental system. The translational value of the current findings is enhanced by the observation that circulating H 2 S levels are lowered not only in streptozotocin-diabetic and in NOD mice (a model of type 1 diabetes) but also in patients with diabetes (41) (42) (43) . We conclude that hyperglycemia produces a H 2 S-deficient state in endothelial cells: H 2 S replacement therapy in hyperglycemic conditions may be of therapeutic potential.
Methods
Cell Culture. The bEnd3 microvascular endothelial cell line was purchased from the American Type Culture Collection, cultured at 37°C at 5% CO 2 , in a humidified chamber, with 5.5. mM glucose containing DMEM with 10% FBS, 2 mM glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin, and 1% LG) or high (HG) glucose for 7 d in the absence or presence of H 2 S treatment (300 μM) was performed by using the Seahorse Biosciences XF24 Analyzer system. In A, a time course for measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) is shown under basal conditions, followed by the sequential addition of oligomycin (1 μg/mL), FCCP (0.3 μM), and antimycin A (2 μg/mL). B shows oxygen consumption rate and mitochondrial reserve capacity, and C shows extracellular acidification rate and glycolytic rate values, representing oxidative phosphorylation and glycolysis, respectively. Hyperglycemia induced a suppression of oxidative phosphorylation and an increase in glycolysis (*P < 0.05), and H 2 S attenuated these changes [ # P < 0.05; n = 15 wells (mean ± SEM) from n = 3 experiments performed on different experimental days]. Fig. 5 . CSE overexpression protects against the development of endothelial dysfunction in thoracic aortic rings placed in elevated extracellular glucose. Rat aortic rings were incubated in low (LG) or high (HG) glucose for 48 h. High glucose suppressed endothelium-dependent relaxant responses (*P < 0.05), an effect that was attenuated in rings overexpressing CSE ( # P < 0.05; n = 4). (Inset) Representative Western blots for CSE in rings exposed to adenovirus expressing GFP or CSE, respectively. nonessential amino acids. Cells were plated in six-well plates at 1 × 10 5 cells per well in a final volume of 2 mL with 5.5 mM DMEM. On the following day, cells were placed in DMEM containing 5.5 mM (low-glucose control) or 40 mM glucose (high glucose). The culture medium was changed every day. After 3 d, 100-300 μM NaHS was added to the wells and reapplied every 8 h until the completion of the experiments. Treatment with 10 μM TTFA, 0.5 μM CCCP, or 10 μM glibenclamide was applied for 3 d. Cells were incubated at 37°C at 5% CO 2 , in a humidified chamber for 7 d, followed by analysis. In another experimental series, the effect of 100-300 μM NaHS was tested on ROS production induced by alternating (12-h cycle) high-/low-glucose conditions. To overexpress CSE in endothelial cells, cells were transfected with an adenoviral plasmid as previously described (44) . For CSE silencing, Silencer Select siRNA for CSE and nonsense control siRNA were obtained from Ambion and were transfected with Lipofectamine 2000.
Measurement of H 2 S Levels. Amperometric H 2 S sensors (WPI) were used for the real-time measurement of dissolved H 2 S concentration in the medium (15) . The amperometric H 2 S sensor was calibrated before each experiment with freshly prepared (anoxic) NaHS stock solution (0-300 μM).
Measurement of Mitochondrial ROS Production. MitoSOX red (Invitrogen), a mitochondrion-specific hydroethidine-derivative fluorescent dye, was used to assess mitochondrial O 2 − production in situ (45) .
Western Blotting. Whole-cell lysate were made by using RIPA buffer with EDTA with a protein protease inhibitor mixture. Equal amounts of protein lysate were separated with 8-12% SDS/PAGE gels, transferred to a 0.45-μm nitrocellulose. The membrane was blocked with 5% low-fat milk in PBS or Tris-buffered saline containing 0.05% Tween-20 and incubated with the primary antibody overnight at 4°C. Primary antibodies for CSE, CBS, and PARP were from Santa Cruz Biotechnology, and for actin, from Sigma.
Measurement of Membrane
Potential by the Fluorescent Dye JC-1. We assessed mitochondrial membrane potential by using JC-1 as described (39) .
Quantitation of DNA Strand Breaks. DNA strand breaks were detected with a single-cell gel electrophoresis assay (14) . DNA strand breaks were quantitated by examining the fixed and stained cells under a fluorescence microscope. The mean length of the DNA tail was determined by measuring 20 cells for each condition.
Cell Viability Assay. The mitochondrial-dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide was used to measure mitochondrial respiration, as an indicator of cell viability (46) .
Bioenergetic Analysis. The XF24 Analyzer (Seahorse Biosciences) was used to measure bioenergetic function in intact bEnd3 cells. The XF24 creates a transient 7-μL chamber in specialized microplates that allows for oxygen Fig. 6 . Improvement of endothelial function by H 2 S in diabetic rats ex vivo.
(A) Streptozotocin-diabetic vehicle-treated rats (STZ/V) exhibit reduced blood H 2 S levels (*P < 0.05), an effect that is normalized by supplementation of H 2 S using the H 2 S-releasing minipumps (STZ/S) ( # P < 0.05). (B) The hyperglycemic response is unaffected by H 2 S-releasing minipumps: *P < 0.05 shows significant and comparable degree of hyperglycemia in STZ rats treated with vehicle or H 2 S-releasing pumps. (C) The thoracic aortas of streptozotocindiabetic rats (STZ/V) exhibit reduced endothelium-dependent relaxant function in response to acetylcholine (1 nM to 30 μM) (*P < 0.05); supplementation of H 2 S using the H 2 S-releasing minipumps (STZ/S) attenuated the degree of this endothelial dysfunction ( # P < 0.05; n = 4-6). consumption rate and extracellular acidification rate or proton production rate to be monitored in real time (40, 47) . To measure indices of mitochondrial function, oligomycin, FCCP, and antimycin A were injected sequentially at the final concentrations of 1 μg/mL, 0.3 μM, and 2 μg/mL, respectively. Using these agents, we determined the basal level of oxygen consumption, the amount of oxygen consumption linked to ATP production, the level of non-ATP-linked oxygen consumption (proton leak), the maximal respiration capacity, and the nonmitochondrial oxygen consumption. Cellular ATP content was measured by a luminescent assay (48) .
Vascular Studies of in Vitro Hyperglycemia. Thoracic aortic rings from SpragueDawley rats were incubated for 48 h under normoglycemic or hyperglycemic conditions in DMEM as described above, in the presence or absence of 200 μM NaHS, applied every 8 h, followed by the determination of endotheliumdependent relaxations (29) . Adenoviral CSE overexpression in vascular rings was performed as described for endothelial cells above, followed by incubation of the rings for 48 h under normoglycemic or hyperglycemic conditions in DMEM. Vascular studies from thoracic aortae wild-type and CSE −/− mice were performed as described (8); rings were incubated either in normoglycemic or hyperglycemic conditions in DMEM for 24 h, followed by the determination of acetylcholine-induced relaxations.
Vascular Studies in Diabetic Rats. Diabetes in male Sprague-Dawley rats was induced with a single streptozotocin injection of 60 mg/kg of body wt i.p. prepared in citrate buffer (pH 4.5). On day 14, animals were implanted with osmotic pumps (Alzet) filled with NaHS (releasing a dose of 16 μg/kg per min) or vehicle. Rats were divided into groups as follows: control group (CTL/V, n = 11, nondiabetic rats treated with vehicle), control with H 2 S (CTL/S, n = 12; nondiabetic rats treated with H 2 S), streptozotocin-induced diabetes group (STZ/V, n = 7; diabetic rats treated with vehicle), and streptozotocin-induced diabetes group (STZ/S, n = 9; diabetic rats treated with H 2 S). (B) Activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) was measured by detection of the poly(ADP ribose) polymers by using Western blotting. High glucose induced an increase in PARP activation (*P < 0.05), and H 2 S (300 μM) afforded a suppression of this response ( # P < 0.05). (Inset) Representative Western blot is shown for the four respective groups (low and high glucose with and without 300 μM H 2 S) (n = 5). Fig. S2 . Acute administration of H 2 S at the end of the hyperglycemic period does not affect mitochondrial oxidant production in endothelial cells placed in high extracellular glucose. Mitochondrial ROS production was measured in low (5.5 mM, LG) or high (40 mM, HG) glucose conditions at 7 d by using the MitoSOX red method, and H 2 S (100-300 μM) was administered for 1 h at the end of the experiment. High glucose increased MitoSOX red oxidation (*P < 0.05), but, when applied according to this protocol, H 2 S failed to affect this response (n = 4). Fig. S3 . The ATP-sensitive potassium (K ATP ) channel inhibitor glibenclamide does not prevent the protective effect of H 2 S in endothelial cells placed in high extracellular glucose. Mitochondrial ROS production was measured in low (5.5 mM, LG) or high (40 mM, HG) glucose conditions at 7 d by using the MitoSOX red method in the presence or absence of H 2 S (300 μM), with and without glibenclamide (10 μM, GLB) pretreatment. Glibenclamide slightly attenuated hyperglycemia-induced MitoSOX red oxidation but failed to influence the protective effect of H 2 S on this response. *P < 0.05 indicates significant increases in MitoSOX red oxidation in high glucose compared with low glucose, and # P < 0.05 indicates significant suppression of this response by H 2 S (n = 4). . Streptozotocin-induced diabetes for 6 wk does not affect the expression of cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS) in various tissues. Representative Western blots for CSE and CBS, loading control (actin), and densitometric analysis are shown in healthy control rats and in rats after 6 wk of streptozotocin-induced diabetes. Only CSE was detected in the thoracic aorta; CSE is more abundant than CBS in the heart, whereas only CBS was detected in the brain (n = 6).
